Modernizing Pharmacovigilance Outsourcing

XTalks

Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. With modern PV applications, companies can easily outsource safety services without losing control or visibility to the data.

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

Pharma Phorum

Parexel’s chief executive Jamie Macdonald said that in the past 18 months, the company “has continued its strong growth trajectory” in a market for outsourced clinical services that at conservative estimates is expected to grow at a rate of 8% to 9% in the coming years.